Advertisement

CardioVascular and Interventional Radiology

, Volume 43, Issue 2, pp 176–185 | Cite as

CIRSE Standards of Practice on Prostatic Artery Embolisation

  • Francois H. CornelisEmail author
  • Tiago Bilhim
  • Nigel Hacking
  • Marc Sapoval
  • Charles R. Tapping
  • Francisco Cesar Carnevale
CIRSE Standards of Practice

Rationale of PAE

Epidemiology Including Clinical Features

Benign prostatic hyperplasia (BPH) is a benign proliferation of stromal and epithelial cells combined with decreased programmed cell death [1], leading to both fibroadenomatous hyperplasia and an increase in the glandular part of the prostate, and thus eventually an enlarged overall prostate volume [2]. BPH produces lower urinary tract symptoms (LUTS), which include an irritative micturition syndrome in the storage phase: increased nycturia, frequent urination of small amounts, involuntary urge to urinate and dysuria, but also bladder outlet obstruction during the emptying phase: delayed start of micturition, prolonged micturition time, weakening of the urinary stream and a feeling of incomplete emptying of the bladder. Prostate size and symptoms are not necessarily correlated. BPH is highly prevalent, affecting up to 50% of males at the age of 50 years and 90% of males over 80 years. It is estimated that symptomatic BPH...

Abbreviations

BPH

Benign prostatic hyperplasia

CBCT

Cone-beam CT

IIEF

International Index of Erectile Function

IPSS

International Prostate Symptom Score

LUTS

Lower urinary tract symptoms

PAE

Prostatic artery embolisation

PErFecTED

Proximal Embolization First, Then Embolize Distal

PSA

Prostate-Specific Antigen

PVR

Post-void residual volume

QOL

Quality of life

TURP

Transurethral resection of the prostate

Notes

Compliance with ethical standards

Conflict of interest

T. Bilhim is on the Advisory Board of Merit Medical, is a consultant for Terumo, a stock holder in the company “Embolx” and has a speaker agreement with Philips. M. Sapoval is a consultant for Merit Medical and has received research grants from BTG and Merit Medical. All other authors declare that they have no conflict of interest.

Supplementary material

270_2019_2379_MOESM1_ESM.pdf (46 kb)
Supplementary material 1 (PDF 46 kb)

References

  1. 1.
    Rio Tinto H, Martins Pisco J, Bilhim T, Duarte M, Fernandes L, Pereira J, et al. Prostatic artery embolization in the treatment of benign prostatic hyperplasia: short and medium follow-up. Tech Vasc Interv Radiol. 2012;15:290–3.PubMedGoogle Scholar
  2. 2.
    Little MW, Boardman P, Macdonald AC, Taylor N, Macpherson R, Crew J, et al. Adenomatous-dominant benign prostatic hyperplasia (AdBPH) as a predictor for clinical success following prostate artery embolization: an age-matched case-control study. Cardiovasc Intervent Radiol. 2017;40:682–9.PubMedGoogle Scholar
  3. 3.
    Christidis D, McGrath S, Perera M, Manning T, Bolton D, Lawrentschuk N. Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies. Prostate Int. 2017;5:41–6.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Antunes AA, Carnevale FC, da Motta Leal Filho JM, Yoshinaga EM, Cerri LMO, Baroni RH, et al. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study. Cardiovasc Intervent Radiol. 2013;36:978–86.PubMedGoogle Scholar
  5. 5.
    Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino ASZZ, Cerri LMOO, et al. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol. 2013;24:535–42.PubMedGoogle Scholar
  6. 6.
    Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;k2338.Google Scholar
  7. 7.
    Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Intervent Radiol. 2016;39:44–52.PubMedGoogle Scholar
  8. 8.
    Golzarian J, Antunes AA, Bilhim T, Carnevale FC, Konety B, McVary KT, et al. Prostatic artery embolization to treat lower urinary tract symptoms related to benign prostatic hyperplasia and bleeding in patients with prostate cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2014;25:665–74.PubMedGoogle Scholar
  9. 9.
    Camara-Lopes G, Mattedi R, Antunes AA, Carnevale FC, Cerri GG, Srougi M, et al. The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia. Int Braz J Urol. 2013;39:222–7.PubMedGoogle Scholar
  10. 10.
    Yu SCH, Cho CCM, Hung EHY, Chiu PKF, Yee CH, Ng CF. Prostate artery embolization for complete urinary outflow obstruction due to benign prostatic hypertrophy. Cardiovasc Intervent Radiol. 2017;40:33–40.PubMedGoogle Scholar
  11. 11.
    Kranse R, van Mastrigt R. Causes for variability in repeated pressure-flow measurements. Urology. 2003;61:930–4 (discussion 934-5).PubMedGoogle Scholar
  12. 12.
    Jørgensen JB, Jensen KM, Mogensen P. Age-related variation in urinary flow variables and flow curve patterns in elderly males. Br J Urol. 1992;69:265–71.PubMedGoogle Scholar
  13. 13.
    Moreira AM, de Assis AM, Carnevale FC, Antunes AA, Srougi M, Cerri GG. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Intervent Radiol. 2017;40:1490–500.PubMedGoogle Scholar
  14. 14.
    Bilhim T, Pisco JM, Furtado A, Casal D, Pais D, Pinheiro LC, et al. Prostatic arterial supply: demonstration by multirow detector Angio CT and Catheter Angiography. Eur Radiol. 2011;21:1119–26.PubMedGoogle Scholar
  15. 15.
    Kim AY, Field DH, DeMulder D, Spies J, Krishnan P. Utility of MR angiography in the identification of prostatic artery origin prior to prostatic artery embolization. J Vasc Interv Radiol. 2018;29(307–310):e1.Google Scholar
  16. 16.
    Tapping CR, Macdonald A, Hadi M, Mortensen C, Crew J, Protheroe A, et al. Prostatic artery embolization (PAE) for benign prostatic hyperplasia (BPH) with haematuria in the absence of an upper urinary tract pathology. Cardiovasc Intervent Radiol. 2018;41:1160–4.PubMedGoogle Scholar
  17. 17.
    Bhatia S, Sinha VK, Kava BR, Gomez C, Harward S, Punnen S, et al. Efficacy of prostatic artery embolization for catheter-dependent patients with large prostate sizes and high comorbidity scores. J Vasc Interv Radiol. 2018;29(78–84):e1.Google Scholar
  18. 18.
    Rampoldi A, Barbosa F, Secco S, Migliorisi C, Galfano A, Prestini G, et al. Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates. Cardiovasc Intervent Radiol. 2017;40:530–6.PubMedGoogle Scholar
  19. 19.
    Wang MQ, Wang Y, Yan JY, Yuan K, Zhang GD, Duan F, et al. Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥ 75 years: a prospective single-center study. World J Urol. 2016;34:1275–83.PubMedGoogle Scholar
  20. 20.
    Chen J-W, Shin JH, Tsao T-F, Ko H-G, Yoon H-K, Han K-C, et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol. 2017;28:295–301.PubMedGoogle Scholar
  21. 21.
    Malling B, Røder MA, Lindh M, Frevert S, Brasso K, Lönn L. Palliative prostate artery embolization for prostate cancer: a case series. Cardiovasc Intervent Radiol. 2019;42:1405–12.PubMedGoogle Scholar
  22. 22.
    Wang MQ, Duan F, Yuan K, Zhang GD, Yan J, Wang Y. Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy. Radiology. 2017;282:271–80.PubMedGoogle Scholar
  23. 23.
    Bagla S, Rholl KS, Sterling KM, van Breda A, Papadouris D, Cooper JM, et al. Utility of cone-beam CT imaging in prostatic artery embolization. J Vasc Interv Radiol. 2013;24:1603–7.PubMedGoogle Scholar
  24. 24.
    Andrade G, Khoury HJ, Garzón WJ, Dubourcq F, Bredow MF, Monsignore LM, et al. Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study. J Vasc Interv Radiol. 2017;28:517–21.PubMedGoogle Scholar
  25. 25.
    Bhatia S, Harward SH, Sinha VK, Narayanan G. Prostate artery embolization via transradial or transulnar versus transfemoral arterial access: technical results. J Vasc Interv Radiol. 2017;28:898–905.PubMedGoogle Scholar
  26. 26.
    Isaacson AJ, Fischman AM, Burke CT. technical feasibility of prostatic artery embolization from a transradial approach. Am J Roentgenol. 2016;206:442–4.Google Scholar
  27. 27.
    Carnevale FC, Soares GR, de Assis AM, Moreira AM, Harward SH, Cerri GG. Anatomical variants in prostate artery embolization: a pictorial essay. Cardiovasc Intervent Radiol. 2017;40:1321–37.PubMedGoogle Scholar
  28. 28.
    DeMeritt JS, Wajswol E, Wattamwar A, Osiason A, Chervoni-Knapp T, Zamudio S. Duplicated prostate artery central gland blood supply: a retrospective analysis and classification system. J Vasc Interv Radiol. 2018;29(1595–1600):e9.Google Scholar
  29. 29.
    de Assis AM, Moreira AM, de Paula Rodrigues VC, Harward SH, Antunes AA, Srougi M, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol. 2015;38:855–61.PubMedGoogle Scholar
  30. 30.
    Garcia-Monaco R, Garategui L, Kizilevsky N, Peralta O, Rodriguez P, Palacios-Jaraquemada J. Human cadaveric specimen study of the prostatic arterial anatomy: implications for arterial embolization. J Vasc Interv Radiol. 2014;25:315–22.PubMedGoogle Scholar
  31. 31.
    Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Pinheiro LC, Furtado A, et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol. 2012;23:1403–15.PubMedGoogle Scholar
  32. 32.
    de Assis AM, Moreira AM, de Paula Rodrigues VC, Yoshinaga EM, Antunes AA, Harward SH, et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26:87–93.PubMedGoogle Scholar
  33. 33.
    Amouyal G, Chague P, Pellerin O, Pereira H, Del Giudice C, Dean C, et al. Safety and efficacy of occlusion of large extra-prostatic anastomoses during prostatic artery embolization for symptomatic BPH. Cardiovasc Intervent Radiol. 2016;39:1245–55.PubMedGoogle Scholar
  34. 34.
    Bhatia S, Sinha V, Bordegaray M, Kably I, Harward S, Narayanan G. Role of coil embolization during prostatic artery embolization: incidence, indications, and safety profile. J Vasc Interv Radiol. 2017;28(656–664):e3.Google Scholar
  35. 35.
    Amouyal G, Pellerin O, Del Giudice C, Déan C, Thiounn N, Sapoval M. Bilateral arterial embolization of the prostate through a single prostatic artery: a case series. Cardiovasc Intervent Radiol. 2017;40:780–7.PubMedGoogle Scholar
  36. 36.
    Hwang JH, Park SW, Chang IS, Jung S Il, Jeon HJ, Lho YS, et al. Comparison of nonspherical polyvinyl alcohol particles and microspheres for prostatic arterial embolization in patients with benign prostatic hyperplasia. Biomed Res Int. 2017;2017:1–7.Google Scholar
  37. 37.
    Gonçalves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M. Comparative study using 100–300 versus 300–500 μm microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol. 2016;39:1372–8.PubMedGoogle Scholar
  38. 38.
    Isaacson AJ, Raynor MC, Yu H, Burke CT. Prostatic artery embolization using embosphere microspheres for prostates measuring 80–150 cm3: early results from a US Trial. J Vasc Interv Radiol. 2016;27:709–14.PubMedGoogle Scholar
  39. 39.
    Bilhim T, Pisco J, Campos Pinheiro L, Rio Tinto H, Fernandes L, Pereira JA, et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol. 2013;24(1595–602):e1.Google Scholar
  40. 40.
    Bilhim T, Pisco J, Pereira JA, Costa NV, Fernandes L, Campos Pinheiro L, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016;281:289–300.PubMedGoogle Scholar
  41. 41.
    Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED Technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014;37:1602–5.PubMedGoogle Scholar
  42. 42.
    Amouyal G, Thiounn N, Pellerin O, Yen-Ting L, Del Giudice C, Dean C, et al. Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol. 2016;39:367–75.PubMedGoogle Scholar
  43. 43.
    Isaacson AJ, Hartman TS, Bagla S, Burke CT. Initial experience with balloon-occlusion prostatic artery embolization. J Vasc Interv Radiol. 2018;29:85–9.PubMedGoogle Scholar
  44. 44.
    Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, et al. Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27:1115–22.PubMedGoogle Scholar
  45. 45.
    Pisco JM, Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23:2561–72.PubMedGoogle Scholar
  46. 46.
    Gao Y, Huang Y, Zhang R, Yang Y, Zhang Q, Hou M, et al. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate—A prospective, randomized, and controlled clinical trial. Radiology. 2014;270:920–8.PubMedGoogle Scholar
  47. 47.
    Napal Lecumberri S, Insausti Gorbea I, Sáez de Ocariz García A, Solchaga Álvarez S, Cebrián Lostal JL, Monreal Beortegui R, et al. Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial. Res Reports Urol. 2018;Volume 10:17–22.Google Scholar
  48. 48.
    Bagla S, Smirniotopoulos J, Orlando J, Piechowiak R. Cost Analysis of Prostate Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) in the Treatment of Benign Prostatic Hyperplasia. Cardiovasc Intervent Radiol. 2017;40:1694–7.PubMedGoogle Scholar
  49. 49.
    Abt D, Müllhaupt G, Mordasini L, Güsewell S, Markart S, Zumstein V, et al. Outcome Prediction of Prostatic Artery Embolization (PAE): Post hoc analysis of a randomized, open label, non-inferiority trial. BJU Int. 2018;.Google Scholar
  50. 50.
    Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361:k2338.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Kurbatov D, Russo GI, Lepetukhin A, Dubsky S, Sitkin I, Morgia G, et al. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study. Urology. 2014;84:400–4.PubMedGoogle Scholar
  52. 52.
    Maclean D, Harris M, Drake T, Maher B, Modi S, Dyer J, et al. Factors Predicting a Good Symptomatic Outcome After Prostate Artery Embolisation (PAE). Cardiovasc Intervent Radiol. 2018;41:1152–9.PubMedGoogle Scholar
  53. 53.
    Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122:270–82.PubMedGoogle Scholar
  54. 54.
    Kisilevzky N, Laudanna Neto C, Cividanes A. Ischemia of the Glans Penis following Prostatic Artery Embolization. J Vasc Interv Radiol. 2016;27:1745–7.PubMedGoogle Scholar
  55. 55.
    Moschouris H, Stamatiou K, Kornezos I, Kartsouni V, Malagari K. Favorable Outcome of Conservative Management of Extensive Bladder Ischemia Complicating Prostatic Artery Embolization. Cardiovasc Intervent Radiol. 2018;41:191–6.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2019

Authors and Affiliations

  1. 1.Department of Radiology, Tenon HospitalSorbonne UniversityParisFrance
  2. 2.Department of Interventional Radiology, Saint Louis Hospital and Centro Hospitalar Universitário de Lisboa CentralNova Medical SchoolLisbonPortugal
  3. 3.Clinical RadiologySouthampton University HospitalsSouthamptonUK
  4. 4.Vascular and Oncologic Interventional Radiology DepartmentGeorges Pompidou European HospitalParisFrance
  5. 5.Faculty of MedicineParis Descartes UniversityParisFrance
  6. 6.INSERM U970ParisFrance
  7. 7.Department of RadiologyChurchill HospitalOxfordUK
  8. 8.Department of RadiologyUniversity of Sao Paulo Medical SchoolSão PauloBrazil

Personalised recommendations